{'fraction_non_alphanumeric': 0.024193548387096774, 'fraction_numerical': 0.013440860215053764, 'mean_word_length': 5.205555555555556, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[The treatment of the disease "hypertonia" based on the new recommendations].

Hypertonia is a widespread disease among the population, and one of the most important reasons behind the morbidity and mortality of cardiovascular diseases. In the past few years, recommendations from the American (JNC 7), the European (ESH/ESC 2003) and the Hungarian Hypertonia Associations have been published. The international and domestic recommendations are similar in that they all state that normal and optimal blood pressure is 120/80 Hgmm. The lower limit of hypertonia is specified as 140/90 Hgmm. The reduction of risks is an absolute priority in the treatment of hypertonia. Before starting the administration of medicines, the patient's risk category is identified and a target blood pressure is specified. The treatment strategy is then set up. The recommendations deal in detail with the first choice, the fixed and not fixed combinations of medicines to be administered. All three recommendations pay special attention to the determination of the indicators of preventing thrombocyte aggregation and statin treatments.